Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
2023-07-07 21:00
280 Bio receives IND approval from the FDA for YL-17231
2023-07-07 20:00
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs
2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment
2023-07-06 18:33
Genesis MedTech Receives Approval for Launch in China for ArtiSential™
2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China
2023-07-06 10:38
United Imaging, Kicking off a Birthday Celebration of Five Years in the U.S. Market, Will Debut Three New Scanners at AHRA
2023-07-06 00:00
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development
2023-07-05 22:05
PENTAX MEDICAL ANNOUNCES THE APPOINTMENT OF DAVID HARRISON AS THE NEW PRESIDENT FOR THE AMERICAS
2023-07-05 21:00
Lunit Makes Full-Fledged Entry into the Middle East with Participation in 'Saudi Vision 2030' Healthcare Transformation Project
2023-07-05 21:00
I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC
2023-07-05 20:00
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China
2023-07-05 20:00
BGI CEO Yin Ye Advocates for Global Technology Sharing
2023-07-05 14:17
Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China
2023-07-04 21:16
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer
2023-07-04 20:55
China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy
2023-07-04 20:42
Lunit's AI-Powered Lung Cancer Screening Solution Significantly Affects Radiologists' Diagnostic Determination - Published in Radiology
2023-07-03 21:00
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
2023-07-03 19:00
Henlius Forecasts Profit in 1H 2023
2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease
2023-07-03 08:00
1
87
88
89
90
91
800